Skip to main content

Peer Review reports

From: Efficacy and safety of the combination of camrelizumab and apatinib in the treatment of liver cancer: a systematic review and single-arm meta-analysis

Original Submission
11 Aug 2023 Submitted Original manuscript
4 Dec 2023 Reviewed Reviewer Report
13 Dec 2023 Reviewed Reviewer Report
29 Dec 2023 Author responded Author comments - Min Chen
6 Jan 2024 Reviewed Reviewer Report
9 Jan 2024 Reviewed Reviewer Report
14 Jan 2024 Author responded Author comments - Min Chen
Resubmission - Version 2
29 Dec 2023 Submitted Manuscript version 2
Publishing
23 Jan 2024 Editorially accepted
31 Jan 2024 Article published 10.1186/s12876-024-03144-8

You can find further information about peer review here.

Back to article page